作者: Juan Morote Robles , Jaume Reventós Puigjaner , Andreas Doll , Marina Rigau Resina , Miguel Abal Posada
DOI:
关键词:
摘要: The invention relates to methods and kits for the diagnosis of prostate cancer (PCa) in a subject, assessing or monitoring response therapy subject having PCa progression based on detection alteration expression levels at least one gene selected from group PC A3, PSMA PSGR. as well whether has be subjected biopsy, said serum PSA range within 4-10 ng/mL.